{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:05:34Z","timestamp":1768781134416,"version":"3.49.0"},"reference-count":17,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2018,1,21]],"date-time":"2018-01-21T00:00:00Z","timestamp":1516492800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,1,21]],"date-time":"2018-01-21T00:00:00Z","timestamp":1516492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1111\/jcpt.12663","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T15:06:04Z","timestamp":1516633564000},"page":"353-358","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of fidaxomicin usage patterns and outcomes for<i>Clostridium difficile<\/i>infection across the United States Veterans Health Administration"],"prefix":"10.1155","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-6879","authenticated-orcid":false,"given":"S. E.","family":"Giancola","sequence":"first","affiliation":[{"name":"Pharmacy Service; Oklahoma City VA Health Care System; Oklahoma City OK USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"R. J.","family":"Williams","sequence":"additional","affiliation":[{"name":"Pharmacy Service; Oklahoma City VA Health Care System; Oklahoma City OK USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Gentry","sequence":"additional","affiliation":[{"name":"Pharmacy Service; Oklahoma City VA Health Care System; Oklahoma City OK USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,1,21]]},"reference":[{"key":"10.1111\/jcpt.12663-BIB0001|jcpt12663-cit-0001","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12663-BIB0002|jcpt12663-cit-0002","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/jcpt.12663-BIB0003|jcpt12663-cit-0003","unstructured":"Centers for Disease Control and Prevention Antibiotic resistance threats in the United States, 2013 http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013"},{"key":"10.1111\/jcpt.12663-BIB0004|jcpt12663-cit-0004","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/cid\/cis462","article-title":"Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin","volume":"55","author":"Cornely","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/jcpt.12663-BIB0005|jcpt12663-cit-0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s15010-013-0496-x","article-title":"Treatment of recurrent Clostridium difficile infection: a systematic review","volume":"42","author":"O'Horo","year":"2014","journal-title":"Infection"},{"key":"10.1111\/jcpt.12663-BIB0006|jcpt12663-cit-0006","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1155\/2015\/934594","article-title":"Fidaxomicin: a novel agent for the treatment of Clostridium difficile infection","volume":"26","author":"Zhanel","year":"2015","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1111\/jcpt.12663-BIB0007|jcpt12663-cit-0007","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12663-BIB0008|jcpt12663-cit-0008","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(11)70374-7","article-title":"Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial","volume":"12","author":"Cornely","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/jcpt.12663-BIB0009|jcpt12663-cit-0009","unstructured":"United States Department of Veterans Affairs National Center for Veterans Analysis and Statistics Department of Veterans Affairs Statistics at a Glance 2016 http:\/\/www1.va.gov\/vetdata\/docs\/Quickfacts\/Homepage_slideshow_06_04_16.pdf"},{"key":"10.1111\/jcpt.12663-BIB0010|jcpt12663-cit-0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3201\/eid1205.051064","article-title":"Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003","volume":"12","author":"McDonald","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/jcpt.12663-BIB0011|jcpt12663-cit-0011","unstructured":"United States Census Bureau Census regions and divisions of the United States https:\/\/www2.census.gov\/geo\/pdfs\/maps-data\/maps\/reference\/us_regdiv.pdf"},{"key":"10.1111\/jcpt.12663-BIB0012|jcpt12663-cit-0012","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1128\/AAC.00939-15","article-title":"Clinical and economic benefits of fidaxomicin compared to vancomycin for Clostridium difficile infection","volume":"59","author":"Gallagher","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12663-BIB0013|jcpt12663-cit-0013","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s15010-016-0894-y","article-title":"A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany","volume":"44","author":"Watt","year":"2016","journal-title":"Infection"},{"key":"10.1111\/jcpt.12663-BIB0014|jcpt12663-cit-0014","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1186\/s40064-016-2825-x","article-title":"A multi-center study of fidaxomicin use for Clostridium difficile infection","volume":"5","author":"Shah","year":"2016","journal-title":"SpringerPlus"},{"key":"10.1111\/jcpt.12663-BIB0015|jcpt12663-cit-0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/IPC.0000000000000181","article-title":"Fidaxomicin use and clinical outcomes for Clostridium difficile-associated diarrhea","volume":"23","author":"Eiland","year":"2015","journal-title":"Infect Dis Clin Pract"},{"key":"10.1111\/jcpt.12663-BIB0016|jcpt12663-cit-0016","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s15010-017-0981-8","article-title":"Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital","volume":"45","author":"Pichenot","year":"2017","journal-title":"Infection"},{"key":"10.1111\/jcpt.12663-BIB0017|jcpt12663-cit-0017","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0000000000000769","article-title":"Outcomes with fidaxomicin therapy in Clostridium difficile infection","author":"Spiceland","year":"2016","journal-title":"J Clin Gastroenterol"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12663","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12663\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:03:26Z","timestamp":1671818606000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,21]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12663","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1,21]]}}}